Marco Caricato Selected Research

Marco Caricato Research Topics

Disease

9	Colorectal Neoplasms (Colorectal Cancer) 07/2019 - 01/2004
8	Neoplasms (Cancer) 01/2022 - 01/2003
4	Rectal Neoplasms (Rectal Cancer) 01/2022 - 01/2016
2	Fever (Fevers) 08/2022 - 09/2017
2	Carcinoma (Carcinomatosis) 01/2022 - 06/2007
2	Abdominal Pain (Pain, Abdominal) 09/2017 - 08/2008
2	Adenocarcinoma 01/2016 - 01/2006
2	Melanoma (Melanoma, Malignant) 03/2015 - 06/2007
2	Anus Neoplasms (Anal Cancer) 06/2009 - 05/2005
1	Acute Abdomen 08/2022
1	Disease Progression 08/2022
1	Thrombosis (Thrombus) 08/2022
1	Hemorrhage 08/2022
1	Morbid Obesity 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Colonic Neoplasms (Colon Cancer) 01/2022
1	Fatty Liver 01/2022
1	Surgical Wound Infection 01/2021
1	Wounds and Injuries (Trauma) 01/2021
1	Intussusception 01/2020
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2018
1	Leukocytosis (Pleocytosis) 09/2017
1	Stomach Neoplasms (Stomach Cancer) 06/2015
1	Colitis 03/2015
1	Ileitis 03/2015
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2015
1	Renal Cell Carcinoma (Grawitz Tumor) 12/2014
1	Flatulence 01/2014
1	Pancreatitis 08/2008
1	Varicose Veins (Varicose Vein) 08/2008
1	Hepatic Insufficiency 08/2008
1	Hepatocellular Carcinoma (Hepatoma) 08/2008
1	Hemoperitoneum 08/2008
1	Brain Neoplasms (Brain Tumor) 01/2006
1	Lymphatic Metastasis 01/2006
1	Adenoma (Adenomas) 11/2005
1	Carcinogenesis 11/2005
1	Pain (Aches) 05/2005
1	Pathologic Constriction (Stenosis) 05/2005
1	Ulcer 05/2005
1	Rare Diseases (Rare Disease) 01/2003
1	Mediastinal Emphysema (Pneumomediastinum) 02/2002
1	Retropneumoperitoneum 02/2002

Drug/Important Bio-Agent (IBA)

3	Fluorouracil (Carac)FDA LinkGeneric 10/2009 - 01/2004
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2009 - 01/2005
2	Pharmaceutical PreparationsIBA 01/2015 - 04/2007
2	Irinotecan (Camptosar)FDA LinkGeneric 10/2009 - 01/2005
2	Leucovorin (Folinic Acid)FDA Link 10/2009 - 04/2007
2	Proteins (Proteins, Gene)FDA Link 06/2007 - 11/2005
2	XELOXIBA 04/2007 - 01/2005
2	Capecitabine (Xeloda)FDA Link 04/2007 - 01/2005
1	Anti-Bacterial Agents (Antibiotics)IBA 08/2022
1	CollagenIBA 01/2022
1	Trinitrotoluene (TNT)IBA 01/2022
1	ScleroproteinsIBA 01/2022
1	mesoglycanIBA 07/2019
1	Bronchodilator Agents (Bronchodilators)IBA 01/2018
1	Varenicline (Chantix)FDA Link 01/2018
1	GoldIBA 01/2018
1	SmokeIBA 01/2018
1	RamucirumabIBA 06/2015
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 06/2015
1	Monoclonal AntibodiesIBA 03/2015
1	IpilimumabIBA 03/2015
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2015
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 12/2014
1	Sunitinib (Sutent)FDA Link 12/2014
1	Tyrosine Kinase InhibitorsIBA 12/2014
1	Phosphotransferases (Kinase)IBA 12/2014
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 09/2014
1	N-Acetyllactosamine SynthaseIBA 12/2012
1	GalactosyltransferasesIBA 12/2012
1	Messenger RNA (mRNA)IBA 12/2012
1	Biomarkers (Surrogate Marker)IBA 12/2012
1	Cetuximab (Erbitux)FDA Link 10/2009
1	Bevacizumab (Avastin)FDA Link 10/2009
1	Ethanol (Ethyl Alcohol)IBA 08/2008
1	Opioid Analgesics (Opioids)IBA 08/2008
1	Gemcitabine FDA Link 01/2006
1	DNA (Deoxyribonucleic Acid)IBA 11/2005
1	Thymidylate SynthaseIBA 01/2004
1	MucinsIBA 01/2003

Therapy/Procedure

8	Drug Therapy (Chemotherapy) 01/2022 - 01/2004
3	Neoadjuvant Therapy 01/2022 - 03/2021
3	Radiotherapy 01/2022 - 05/2005
1	Endoscopic Hemostasis 08/2022
1	Bariatric Surgery 01/2022
1	Length of Stay 01/2021
1	Laparotomy 01/2020
1	Therapeutics 09/2017
1	Surgical Instruments (Clip) 09/2017
1	Colectomy 01/2014
1	Sex Reassignment Surgery 06/2009
1	Immunotherapy 06/2007
1	Pancreaticoduodenectomy 01/2006
1	Proctectomy 05/2005
1	Adjuvant Chemotherapy 01/2004
1	Colostomy 02/2002